Flucytosine (Ancotil): new contraindication in patients with DPD deficiency

Flucytosine can cause life-threatening and severe toxicity in patients with complete and partial DPD deficiency. Although pre-testing of DPD status before treatment is not required, a new contraindication for patients with complete DPD deficiency has been introduced.

Source:

Medicines and Healthcare products Regulatory Agency